| Literature DB >> 29147090 |
Furkan Demirgül1,2, Yasin Tuncer1.
Abstract
The aim of this study was to isolate enterococci in Sucuk, a traditional Turkish dry-fermented sausage and to analyze isolates for their biodiversity, antibiotic resistance patterns and the presence of some antibiotic resistance genes. A total of 60 enterococci strains were isolated from 20 sucuk samples manufactured without using a starter culture and they were identified as E. faecium (73.3%), E. faecalis (11.7%), E. hirae (8.3%), E. durans (3.3%), E. mundtii (1.7%) and E. thailandicus (1.7%). Most of the strains were found resistant to rifampin (51.67%) followed by ciprofloxacin (38.33%), nitrofurantoin (33.33%) and erythromycin (21.67%). All strains were found susceptible to ampicillin. Only E. faecium FYE4 and FYE60 strains displayed susceptibility to all antibiotics. Other strains showed different resistance patterns to antibiotics. E. faecalis was found more resistant to antibiotics than other species. Most of the strains (61.7%) displayed resistance from between two and eight antibiotics. The ermB, ermC, gyrA, tetM, tetL and vanA genes were detected in some strains. A lack of correlation between genotypic and phenotypic analysis for some strains was detected. The results of this study indicated that Sucuk manufactured without using a starter culture is a reservoir of multiple antibiotic resistant enterococci. Consequently, Sucuk is a potential reservoir for the transmission of antibiotic resistance genes from animals to humans.Entities:
Keywords: Enterococcus; PCR; antibiotic resistance; antibiotic resistance gene; sucuk
Year: 2017 PMID: 29147090 PMCID: PMC5686325 DOI: 10.5851/kosfa.2017.37.5.670
Source DB: PubMed Journal: Korean J Food Sci Anim Resour ISSN: 1225-8563 Impact factor: 2.622
PCR primers and annealing temperatures for detection of antibiotic resistance genes
| Genes | Primer sequence (5' to 3') | Annealing temperature (°C) | Reference |
|---|---|---|---|
| GCGAACGAAAAACAATTGCA | 55 | ( | |
| TGAAGCTGTAAGGCAACTGG | |||
| GAYTATGCWATGTCAGTTATTGT | 45 | ( | |
| GGAATRTTRGAYGTCATACCAAC | |||
| AAGCGGTAAAACCCCTCTGAG | 55 | ( | |
| TCAAAGCCTGTCGGAATTGG | |||
| CATTTAACGACGAAACTGGC | 52 | ( | |
| GGAACATCTGTGGTATGGCG | |||
| CAAACCCGTATTCCACGATT | 48 | ( | |
| ATCTTTGAAATCGGCTCAGG | |||
| GTTAAATAGTGTTCTTGGAG | 45 | ( | |
| CTAAGATATGGCTCTAACAA | |||
| GTTGCGCGCTATATTCCAAA | 54 | ( | |
| TTAAGCAAACTCATTCCAGC | |||
| TGGAACGCCAGAGAGGTATT | 55 | ( | |
| ACATAGACAAGCCGTTGACC | |||
| TTAGGTGAAGGGTTAGGTCC | 55 | ( | |
| GCAAACTCATTCCAGAAGCA | |||
| GATGGCATACAGGCACAGAC | 55 | ( | |
| CAATATCACCAGAGCAGGCT | |||
| GGGAAAACGACAATTGC | 54 | ( | |
| GTACAATGCGGCCGTTA | |||
| GTGCTGCGAGATACCACAGA | 54 | ( | |
| CGAACACCATGCAACATTTC | |||
| GGTATCAAGGAAACCTC | 54 | ( | |
| CTTCCGCCATCATAGCT |
Y, C or T; R, A or G; W, A or T.
Fig. 1.Phylogenetic analysis of 16S rRNA gene sequences of Enterococcus strains.
Antibiotic resistance of Enterococcus strains isolated from Sucuk and positive PCR for resistance genes in these strains
| Strains | Antibiotic susceptibility1) | Positive PCR/resistance genes | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | DO | E | CN | C | LEV | LZD | QD | MH | F | NOR | P | RD | CIP | S | TEC | TE | VA | ||
| S2) | I | R | R | R | S | S | R | I | S | I | S | S | R | R | I | I | S | ||
| S | S | I | S | S | I | S | S | S | R | I | S | R | R | S | I | S | S | ermC | |
| S | I | R | R | R | I | I | R | R | S | I | S | S | R | R | R | I | S | ||
| S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | ermB | |
| S | S | R | S | S | R | I | S | S | R | R | S | R | R | S | I | S | S | ||
| S | S | I | S | S | S | S | S | S | S | S | S | S | I | S | S | S | S | none | |
| S | S | R | S | S | S | S | S | S | S | R | S | S | S | S | I | S | S | none | |
| S | S | I | S | S | S | S | S | S | S | S | S | S | I | S | I | S | S | ermC | |
| S | S | S | S | S | S | S | S | S | I | S | S | S | I | S | I | S | S | none | |
| S | S | I | S | S | I | S | S | S | S | I | S | S | I | S | I | S | S | none | |
| S | S | I | S | S | I | I | S | S | R | I | S | R | R | S | I | S | S | ermC | |
| S | S | I | S | S | I | I | S | S | R | I | S | R | R | S | I | S | S | none | |
| S | S | I | S | S | S | S | S | S | R | S | S | S | S | S | I | S | S | none | |
| S | R | R | S | R | I | I | R | R | S | I | S | R | I | R | I | R | I | ||
| S | S | I | S | S | I | S | S | S | R | I | S | R | I | S | I | S | S | tetM | |
| S | S | S | S | S | R | S | I | S | R | S | S | S | R | S | R | S | I | ||
| S | S | R | S | S | I | I | I | S | S | I | S | R | I | S | I | S | S | gyrA | |
| S | S | I | S | S | I | I | I | S | R | I | S | R | I | S | I | S | I | none | |
| S | S | S | S | S | S | S | I | S | I | S | S | I | I | S | S | S | S | gyrA | |
| S | S | I | S | S | S | I | S | S | R | R | S | R | R | S | I | S | S | ermC | |
Antibiotic susceptibility and resistance percentage of Enterococcus strains
| Antibiotics | Concentration (µg/disc) | Sensitive (%) | Intermediary (%) | Resistance (%) |
|---|---|---|---|---|
| Ampicillin | 10 | 100 | 0 | 0 |
| Chloramphenicol | 30 | 90 | 1.67 | 8.33 |
| Ciprofloxacin | 5 | 13.33 | 48.33 | 38.33 |
| Doxycycline | 30 | 88.33 | 8.33 | 3.33 |
| Erythromycin | 15 | 15 | 63.33 | 21.67 |
| Gentamicin | 120 | 93.33 | 1.67 | 5 |
| Levofloxacin | 5 | 51.67 | 41.67 | 6.67 |
| Linezolid | 30 | 70 | 28.33 | 1.67 |
| Minocycline | 30 | 90 | 5 | 5 |
| Nitrofurantoin | 300 | 50 | 16.67 | 33.33 |
| Norfloxacin | 10 | 40 | 50 | 10 |
| Penicillin G | 101) | 90 | 0 | 10 |
| Quinupristin/dalfopristin | 15 | 63.33 | 26.67 | 10 |
| Rifampin | 5 | 35 | 13.33 | 51.67 |
| Streptomycin | 300 | 93.33 | 0 | 6.67 |
| Teicoplanin | 30 | 23.33 | 68.33 | 8.33 |
| Tetracycline | 30 | 88.33 | 6.67 | 5 |
| Vancomycin | 30 | 86.67 | 11.67 | 1.67 |
1)Penicillin G 10 U/disc.
Antıbiotic susceptibility and resistance per cent of E. faecium, E. faecalis, E. hirae, E. durans, E. mundtii and E. thailandicus strains isolated from Sucuk
| Antibiotics | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S2) | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | |
| Ampicillin | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Chloramphenicol | 97.73 | 0 | 2.27 | 28.57 | 14.29 | 57.14 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Ciprofloxacin | 15.91 | 38.64 | 45.45 | 0 | 57.14 | 42.86 | 20 | 80 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 |
| Doxycycline | 95.46 | 2.27 | 2.27 | 28.57 | 57.14 | 14.29 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Erythromycin | 11.36 | 75 | 13.64 | 0 | 28.57 | 71.43 | 80 | 20 | 0 | 0 | 50 | 50 | 0 | 100 | 0 | 0 | 0 | 100 |
| Gentamicin | 100 | 0 | 0 | 42.86 | 14.29 | 42.86 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Levofloxacin | 50 | 40.91 | 9.09 | 42.86 | 57.14 | 0 | 100 | 0 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 0 |
| Linezolid | 77.27 | 22.73 | 0 | 28.57 | 57.14 | 14.29 | 100 | 0 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 0 |
| Minocycline | 97.73 | 2.27 | 0 | 28.57 | 28.57 | 42.86 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Nitrofurantoin | 45.45 | 20.45 | 34.09 | 85.71 | 0 | 14.29 | 20 | 20 | 60 | 50 | 0 | 50 | 100 | 0 | 0 | 100 | 0 | 0 |
| Norfloxacin | 38.64 | 47.73 | 13.64 | 0 | 100 | 0 | 100 | 0 | 0 | 50 | 50 | 0 | 100 | 0 | 0 | 0 | 100 | 0 |
| Penicillin G | 88.64 | 0 | 11.36 | 100 | 0 | 0 | 100 | 0 | 0 | 50 | 0 | 50 | 100 | 0 | 0 | 100 | 0 | 0 |
| Quinupristin/dalfopristin | 79.55 | 20.45 | 0 | 14.29 | 0 | 85.71 | 20 | 80 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 100 | 0 |
| Rifampin | 38.64 | 4.55 | 56.82 | 28.57 | 28.57 | 42.86 | 20 | 80 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 100 |
| Streptomycin | 100 | 0 | 0 | 42.86 | 0 | 57.14 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Teicoplanin | 29.55 | 65.91 | 4.55 | 0 | 71.43 | 28.57 | 20 | 80 | 0 | 0 | 50 | 50 | 0 | 100 | 0 | 0 | 100 | 0 |
| Tetracycline | 95.45 | 0 | 4.55 | 28.57 | 57.14 | 14.29 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
| Vancomycin | 90.91 | 9.09 | 0 | 42.86 | 42.86 | 14.29 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
1)n, number of strain.
2)S, susceptible; I, intermediary; R, resistance.
Fig. 2.PCR screen for Order line 1, E. faecalis FYE1; line 2, E. faecium FYE2; line 3, E. faecalis FYE3; line 4, E. faecium FYE4; line 5, E. faecium FYE5; line 6, E. faecium FYE6; line 7, E. faecium FYE7; line 8, E. faecium FYE8; line 9, E. faecium FYE9; line 10, E. faecium FYE10; line M, 100 bp DNA ladder (Fermentas); line 11, E. faecalis FYE11; line 12, E. faecium FYE12; line 13, E. faecium FYE13; line 14, E. faecalis FYE14; line 15, E. faecium FYE15; line 16, E. faecium FYE16; line 17, E. thailandicus FYE17; line 18, E. faecium FYE18; line 19, negative control.
Antibiotic resistance of Enterococcus strains isolated from Sucuk and positive PCR for resistance genes in these strains
| Strains | Antibiotic susceptibility1) | Positive PCR/resistance genes | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | DO | E | CN | C | LEV | LZD | QD | MH | F | NOR | P | RD | CIP | S | TEC | TE | VA | ||
| S | S | I | S | S | I | S | S | S | R | R | R | R | R | S | I | S | S | none | |
| S | S | I | S | S | I | I | S | S | R | I | R | R | R | S | I | S | S | ermC | |
| S | S | I | S | S | I | S | S | S | R | I | R | R | R | S | I | S | S | ermC | |
| S | S | I | S | S | S | S | S | S | R | I | S | R | I | S | I | S | S | ermC | |
| S | S | I | S | S | S | S | S | S | S | S | S | S | I | S | I | S | S | none | |
| S | S | I | S | S | I | S | S | S | I | I | S | R | R | S | I | S | S | none | |
| S | I | R | I | I | S | I | R | I | S | I | S | I | I | S | I | I | I | ermB | |
| S | S | I | S | S | I | I | I | S | R | I | R | S | R | S | R | S | S | ermC | |
| S | S | I | S | S | I | R | R | S | S | I | S | R | I | S | R | S | R | none | |
| S | S | S | S | S | S | S | I | S | R | S | S | I | I | S | I | S | S | gyrA | |
| S | S | S | S | S | S | S | I | S | R | S | S | S | I | S | I | S | S | gyrA | |
| S | R | S | S | S | S | S | S | S | S | S | S | R | S | S | S | R | S | tetL | |
| S | S | I | S | S | S | I | I | S | S | I | S | S | I | S | I | S | I | ||
| S | S | I | S | S | I | I | I | S | S | I | R | R | I | S | I | S | S | none | |
| S | S | I | S | S | R | I | S | S | I | R | S | S | R | S | I | S | I | none | |
| S | S | I | S | S | S | S | S | S | S | S | S | I | S | S | I | S | S | gyrA | |
| S | I | R | S | R | I | I | I | I | S | R | S | S | R | S | I | R | S | ||
| S | S | I | S | S | S | S | S | S | S | S | S | R | S | S | I | S | S | tetM | |
| S | S | I | S | S | I | S | S | S | I | S | S | I | I | S | I | S | S | none | |
| S | S | I | S | S | S | S | S | S | R | I | S | R | I | S | S | S | S | ermC | |
| S | S | R | S | S | S | S | S | S | S | S | S | R | S | S | I | S | S | ||
| S | S | I | S | S | I | S | S | S | S | S | S | R | I | S | I | S | S | none | |
| S | S | I | S | S | I | I | S | S | S | I | S | R | R | S | I | S | S | none | |
| S | S | R | S | S | I | I | I | S | R | S | S | R | I | S | R | S | S | gyrA | |
| S | S | R | S | S | I | S | S | S | S | I | S | R | R | S | I | S | S | none | |
| S | S | R | S | S | R | S | S | S | R | I | R | I | R | S | I | S | S | ermC | |
| S | S | I | S | S | S | S | I | S | S | S | S | S | I | S | I | S | S | none | |
| S | S | I | S | S | S | S | I | S | S | S | S | S | I | S | I | S | S | none | |
| S | S | I | S | S | S | S | I | S | S | S | S | S | I | S | S | S | S | none | |
| S | S | I | S | S | S | S | I | S | S | S | S | S | I | S | I | S | S | none | |
| S | I | R | R | R | S | S | R | R | S | I | S | I | I | R | I | I | I | ||
| S | S | I | S | S | I | S | S | S | I | I | S | R | R | S | S | S | S | none | |
| S | S | I | S | S | S | S | S | S | I | I | S | R | R | S | S | S | S | none | |
| S | S | I | S | S | S | S | S | S | S | I | S | R | I | S | S | S | S | none | |
| S | S | I | S | S | I | S | S | S | I | I | S | R | R | S | S | S | S | none | |
| S | S | I | S | S | I | S | S | S | S | S | S | R | I | S | S | S | S | none | |
| S | S | I | S | S | S | S | S | S | I | I | S | R | R | S | S | S | S | none | |
| S | S | I | S | S | S | S | S | S | I | I | S | R | R | S | S | S | S | none | |
| S | S | S | S | S | S | S | I | S | R | S | S | I | I | S | I | S | S | ||
| S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | none | |
1)AMP, Ampicillin (10 μg); C, Chloramphenicol (30 μg); CIP, Ciprofloxacin (5 μg); CN, Gentamisin (120 μg); DO, Doxycycline (30 μg); E, Erythromycin (15 μg); F, Nitrofurantoin (300 μg); LEV, Levofloxacin (5 μg); LZD, Linezolid (30 μg); MH, Minocycline (30 μg); NOR, Norfloxacin (10 μg); P, Penicillin G (10 U); QD, Quinupristin/dalfopristin (15 μg); RD, Rifampin (5 μg); S, Streptomycin (300 μg); TEC, Teicoplanin (30 μg); TE, Tetracycline (30 μg); VA, Vancomycin (30 μg).
2)S, susceptible; I, intermediary; R, resistance.